{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:58:08Z","timestamp":1791903488189,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.suc.2020.02.013","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T17:50:37Z","timestamp":1587059437000},"page":"535-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Primary Liver Cancers"],"prefix":"10.1016","volume":"100","author":[{"given":"Juan C.","family":"Mejia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2020.02.013_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jamcollsurg.2008.09.007","article-title":"Evidence-based approach to cholangiocarcinoma: a systemic review of current literature","volume":"208","author":"Aljiffry","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.suc.2020.02.013_bib2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suc.2020.02.013_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.suc.2020.02.013_bib4","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.suc.2020.02.013_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one year experience with 564 patients at a s single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.suc.2020.02.013_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2020.02.013_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s002610000079","article-title":"Intrahepatic peripheral cholangiocarcinoma: CT evaluation","volume":"25","author":"Valls","year":"2000","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.suc.2020.02.013_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jmri.1880050210","article-title":"Contrast enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study","volume":"5","author":"Murakami","year":"1995","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"10","key":"10.1016\/j.suc.2020.02.013_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2147\/OTT.S93629","article-title":"Intrahepatic cholangiocarcinoma: current perspectives","author":"Buettner","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.suc.2020.02.013_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"95","author":"LaRusso","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.013_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jhbp.157","article-title":"Surgical Treatment of intrahepatic cholangiocarcinoma in the USA","volume":"22","author":"Lubezky","year":"2014","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.suc.2020.02.013_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejro.2014.07.001","article-title":"Current update on combined hepatocellular-cholangiocarcinoma","volume":"1","author":"Maximin","year":"2014","journal-title":"Eur J Radiol Open"},{"issue":"8","key":"10.1016\/j.suc.2020.02.013_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"Weber","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.suc.2020.02.013_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archsurg.2012.1962","article-title":"Surgical approach for long term survival of patients with intrahepatic cholangiocarcinoma a multi-institutional analysis of 434 patients","volume":"147","author":"Ribero","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.suc.2020.02.013_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/ejso.1999.0660","article-title":"Peripheral cholangiocarcinoma: presentation, diagnosis, pathology, and management","volume":"25","author":"Ek Rassie","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.013_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival and determinants of outcome after resection","volume":"243","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.suc.2020.02.013_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma the AJCC\/UICC 8th edition updates","volume":"7","author":"Lee","year":"2018","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.suc.2020.02.013_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00464-005-0583-x","article-title":"Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma","volume":"20","author":"Goere","year":"2006","journal-title":"Surg Enodsc"},{"key":"10.1016\/j.suc.2020.02.013_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1245\/ASO.2003.03.091","article-title":"The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases","volume":"10","author":"D\u2019Angelica","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.013_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jso.24720","article-title":"Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis","volume":"116","author":"Kim","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"23","key":"10.1016\/j.suc.2020.02.013_bib21","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","article-title":"Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment","volume":"29","author":"Mechteld de Jong","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.suc.2020.02.013_bib22","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","article-title":"Trends in survival after surgery for cholangiocarcinoma: a 30 year population based SEER database analysis","volume":"11","author":"Nathan","year":"2007","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.suc.2020.02.013_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.suc.2020.02.013_bib24","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","article-title":"Intrahepatic cholangiocarcinoma: an international multi-institution analysis of prognostic factors and lymph node assessment","volume":"29","author":"De Jong","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2020.02.013_bib25","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","article-title":"The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection on survival","volume":"16","author":"Choi","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.013_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer( BILCAP): a randomized, controlled, multicenter, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.suc.2020.02.013_bib27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2020.02.013_bib28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/1471-2407-10-492","article-title":"Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients","volume":"10","author":"Chen","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.suc.2020.02.013_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-7-67","article-title":"Clinical outcome toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma","volume":"7","author":"Barney","year":"2012","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.suc.2020.02.013_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crad.2010.11.002","article-title":"Transarterial chemoembolization versus supportive therapy in palliative treatment of resectable intrahepatic cholangiocarcinoma","volume":"66","author":"Park","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.suc.2020.02.013_bib31","first-page":"437","article-title":"Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy","volume":"24","author":"Kulhman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2020.02.013_bib32","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23818","article-title":"Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study","volume":"113","author":"Ibrahim","year":"2008","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.suc.2020.02.013_bib33","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1002\/cncr.28312","article-title":"Multidisciplinary approaches to intrahepatic cholangiocarcinoma","volume":"119","author":"Maithel","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2020.02.013_bib34","doi-asserted-by":"crossref","first-page":"W205","DOI":"10.2214\/AJR.10.4937","article-title":"Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma","volume":"196","author":"Kim","year":"2011","journal-title":"AJR AM J Roentgenol"},{"issue":"5","key":"10.1016\/j.suc.2020.02.013_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cncr.29824","article-title":"Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival compared to systemic chemotherapy alone","volume":"122","author":"Konstantinidis","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2020.02.013_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/tgh.2018.07.02","article-title":"Precision medicine in cholangiocarcinoma","volume":"3","author":"Pellino","year":"2018","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2020.02.013_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.suc.2020.02.013_bib38","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2020.02.013_bib39","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.2015.64.7412","article-title":"Futures of hepatocellular carcinoma incidence in the United States forecast through 2030","volume":"34","author":"Petrick","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.suc.2020.02.013_bib40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3748\/wjg.v13.i3.414","article-title":"Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma","volume":"13","author":"Uka","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.suc.2020.02.013_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.suc.2020.02.013_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2020.02.013_bib43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2020.02.013_bib44","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.25536","article-title":"Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease","volume":"55","author":"Reddy","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.suc.2020.02.013_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MCG.0000000000001075","article-title":"Inadequate hepatocellular carcinoma screening in patients with nonalcoholic steatohepatitis cirrhosis","volume":"53","author":"Aby","year":"2019","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.013_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.suc.2020.02.013_bib47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.suc.2020.02.013_bib48","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/jgh.14108","article-title":"Incidence and risk factors associated with hepatocellular carcinoma surveillance failure","volume":"33","author":"Mancebo","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.013_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/0003-4819-139-1-200307010-00012","article-title":"Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis","volume":"139","author":"Gupta","year":"2003","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.suc.2020.02.013_bib50","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0016-5085(84)80151-1","article-title":"Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma","volume":"86","author":"Chen","year":"1984","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.suc.2020.02.013_bib51","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.11.020","article-title":"Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy\u2014a systematic review","volume":"159","author":"Van der Pol","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2020.02.013_bib52","author":"Benson"},{"key":"10.1016\/j.suc.2020.02.013_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.sla.0000250420.73854.ad","article-title":"Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility","volume":"245","author":"Pawlik","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2020.02.013_bib54","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/1078-0432.CCR-14-0122","article-title":"Intratumor heterogeneity in hepatocellular carcinoma","volume":"21","author":"Friemel","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.suc.2020.02.013_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1055-3207(02)00090-X","article-title":"Selective approach to major hepatic resection for hepatocellular carcinoma in chronic liver disease","volume":"12","author":"Kianmanesh","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.suc.2020.02.013_bib56","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention to treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2020.02.013_bib57","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2471070818","article-title":"Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy","volume":"247","author":"Yamakado","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.suc.2020.02.013_bib58","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1245\/s10434-010-0976-5","article-title":"Surgical resection of high-risk hepatocellular carcinoma; patient selection, preoperative considerations, and operative technique","volume":"17","author":"Truty","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.013_bib59","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patient with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2020.02.013_bib60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end stage liver disease","volume":"33","author":"Kmath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2020.02.013_bib61","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1600-6143.2010.03127.x","article-title":"Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system","volume":"10","author":"Washburn","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.suc.2020.02.013_bib62","unstructured":"Organ Procurement and Transplantation Network (OPTN). Allocation of liver and liver-intestines. Available at: https:\/\/optn.transplant.hrsa.gov\/media\/1200\/optn_policies.pdf. Accessed April 6, 2020."},{"issue":"6","key":"10.1016\/j.suc.2020.02.013_bib63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/apt.14929","article-title":"Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis","volume":"48","author":"Liu","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.suc.2020.02.013_bib64","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2020.02.013_bib65","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4254\/wjh.v8.i18.770","article-title":"Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: a systematic review and meta-analysis","volume":"8","author":"Facciorusso","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.suc.2020.02.013_bib66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2016.02.027","article-title":"Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis","volume":"95","author":"Bush","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.suc.2020.02.013_bib67","first-page":"34","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"452","author":"Wahl","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2020.02.013_bib68","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2020.02.013_bib69","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma; a randomized phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:11:36Z","timestamp":1758539496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610920300268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0039610920300268"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.013","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Liver Cancers","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}